Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
02/1996
02/27/1996CA1338089C Sulfonic acid esters
02/22/1996WO1996005220A1 Compounds for use in treatment of carcinomas
02/22/1996WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it
02/22/1996WO1996005218A1 Delivery of nucleic acids
02/22/1996WO1996005160A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
02/22/1996DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer
02/21/1996EP0474767B1 Dopamine agonists
02/20/1996US5492920 Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
02/20/1996US5492916 Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
02/20/1996US5492896 Pseudopeptides having an antiviral action
02/20/1996US5492895 Inhibitors of thrombosis
02/15/1996WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex
02/15/1996WO1996004298A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
02/15/1996WO1996004242A1 Arylthio compounds as antibacterial and antiviral agents
02/15/1996WO1996004002A1 Remedy for corneal diseases
02/15/1996WO1996003987A1 Lactone compounds for treating patients with precancerous lesions
02/15/1996WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors
02/15/1996CA2196687A1 Corneal therapeutic agent
02/15/1996CA2196450A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
02/15/1996CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors
02/15/1996CA2193845A1 Arylthio compounds as antibacterial and antiviral agents
02/15/1996CA2172710A1 Lactone compounds for treating patients with precancerous lesions
02/14/1996EP0696593A2 Inhibitors of farnesyl protein transferase
02/14/1996EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
02/14/1996EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
02/14/1996CN1116847A N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists
02/14/1996CN1116628A Cyclopeptides of the formulal
02/14/1996CN1116627A New peptides derived from trifluorumethylketones, process for their preparation and the pharmaceutical compositions which contain them
02/13/1996US5491143 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE
02/13/1996US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
02/13/1996US5491074 Joining peptides by attaching association hexapeptide to each, mixing fusion complexes formed to dimerize association peptide
02/13/1996US5491073 Cloning of chicken anaemia DNA
02/12/1996CA2155448A1 Inhibitors of farnesyl protein transferase
02/09/1996CA2155496A1 Nucleic acid-binding oligomers for therapy and diagnosis
02/08/1996WO1996003428A1 Antiprotozoal cyclic tetrapeptides
02/08/1996WO1996003427A1 Peptide derived radionuclide chelators
02/08/1996WO1996003424A1 Combinatorial libraries of molecules and methods for producing same
02/08/1996WO1996003374A1 Thrombin inhibitors
02/08/1996CA2195089A1 Combinatorial libraries of molecules and methods for producing same
02/08/1996CA2194999A1 Antiprotozoal cyclic tetrapeptides
02/08/1996CA2194551A1 Peptide derived radionuclide chelators
02/08/1996CA2193844A1 Thrombin inhibitors
02/07/1996EP0695759A2 Human cancer inhibitory pentapeptide methyl esters
02/07/1996EP0695758A2 Human cancer inhibitory pentapeptide amides and esters
02/07/1996EP0695757A2 Human cancer inhibitory peptide amides
02/07/1996EP0695308A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
02/07/1996EP0695184A1 Hiv protease inhibitors
02/07/1996CN1030922C Process for preparation of new amino acid derivatives
02/06/1996US5489583 2-substituted 3-(4-amidinophenyl)propionic acid derivatives
02/02/1996CA2154206A1 Human cancer inhibitory pentapeptide amides and esters
02/02/1996CA2154205A1 Human cancer inhibitory peptide amides
02/02/1996CA2154203A1 Pentapeptide methyl esters
02/01/1996WO1996002564A1 Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
02/01/1996WO1996002558A1 Linked peptide nucleic acids
02/01/1996WO1996002552A1 Lung cancer marker
02/01/1996WO1996002549A1 SUBSTITUTED THIAZOLO[3,2-α]AZEPINE DERIVATIVE
02/01/1996WO1996002517A1 Substituted arylsulfonamides, their preparation and use as thrombin-inhibiting medicaments
02/01/1996WO1996002499A1 Difluorostatone antiviral agents
02/01/1996WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it
02/01/1996CA2195403A1 Lung cancer marker
01/1996
01/31/1996EP0694041A1 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE
01/31/1996EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity
01/31/1996EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
01/31/1996EP0693941A1 Radiolabeled compounds for thrombus imaging
01/31/1996EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy
01/31/1996EP0593557B1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
01/30/1996US5488157 β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
01/30/1996US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace
01/30/1996US5488047 Hypotensive agents, analgesics; congestive heart failure
01/30/1996US5488037 Antithrombotic agents
01/30/1996CA1338015C Process for industrially synthesizing 2(2s, 3as, 7as) perhydroindole-2-carboxylic acid
01/25/1996WO1996001841A1 Cationic lipids for delivery of nucleic acids to cells
01/25/1996WO1996001840A1 Cationic lipids for delivery of nucleic acids to cells
01/25/1996WO1996001655A1 Cascade-polymer complexes and methods of producing the same
01/25/1996WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases
01/25/1996WO1996001645A1 Use of muramyl peptide compounds
01/25/1996WO1996001644A1 Inhibitors of leukocyte adhesion
01/25/1996CA2194678A1 Use of muramyl peptide compounds
01/25/1996CA2194560A1 Cascade-polymer complexes and methods of producing the same
01/25/1996CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases
01/25/1996CA2193508A1 Inhibitors of leukocyte adhesion
01/24/1996EP0693129A1 Method of inhibiting the transcription of genes
01/24/1996EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis
01/24/1996EP0693082A1 Immuno modulated peptide derivatives of leukokinin fragments
01/24/1996EP0693081A1 Cyclic compounds and compositions which inhibit bone resorption
01/24/1996EP0693064A1 Hydrophobic aminocoumarin derivatives and their use as proteolytic enzyme substrates or in the preparation of such substrates
01/24/1996EP0692982A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
01/24/1996EP0692979A1 Bifunctional chelators and their use in radiopharmaceuticals
01/24/1996EP0692968A1 Urokinase plasminogen activator fragments
01/24/1996EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof
01/23/1996US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase
01/23/1996US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace
01/23/1996US5486466 Enzyme inhibitors
01/18/1996DE4424828A1 Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted aryl sulfonamides, their preparation and their use as medicaments
01/17/1996EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
01/17/1996EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
01/17/1996EP0691985A1 Phosphonomethyldipeptides
01/17/1996EP0493480B1 Dehydrodidemnin b
01/17/1996CN1114961A Peptide inhibitors of cell adhesion
01/17/1996CN1030703C Neurokinin A antagonists